How to Get GLP-1 Patients as a Prescriber in Michigan

You’re already managing complex medication regimens and behavioral change with your psychiatric patients. Now there’s a massive opportunity knocking: GLP-1 weight-loss medications. By 2025, an estimated 6% of Americans (20 million people) were taking GLP-1 drugs like semaglutide or tirzepatide—a staggering 600% increase in weight-loss usage over just six years.

Here’s what most psychiatrists don’t realize: You’re already positioned to win in this market.

You understand psychopharmacology. You manage chronic conditions. You counsel patients through difficult behavioral changes. And many of your current patients are already asking about these medications—especially those dealing with antipsychotic-induced weight gain.

But here’s the question every psychiatrist considering this opportunity asks: Can I actually scale a GLP-1 practice without adding another 20 hours to my week?

The answer is yes—if you build it right. Let’s walk through exactly how.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

The Patient Demand Is Real (And Growing)

The obesity epidemic affects roughly 75% of Americans, and traditional approaches haven’t worked for most. GLP-1 medications changed that equation. These drugs produce dramatic results—average weight loss of 15-20% of body weight—and patients are hungry for access.

A late-2023 survey found that nearly half of psychiatrists were already prescribing or recommending Ozempic or similar weight-loss drugs. Why? Because the overlap between psychiatric care and obesity is undeniable:

• Medication-induced weight gain is one of the top reasons patients discontinue antipsychotics and mood stabilizers
• Binge eating disorder, emotional overeating, and food addiction frequently co-occur with depression and anxiety
• The psychological component of weight loss—motivation, self-image, dealing with setbacks—is where most weight-loss programs fail, but it’s exactly where psychiatrists excel

Unlike primary care doctors who squeeze in 15-minute visits or obesity medicine specialists who may lack mental health training, you bring a holistic approach. You can address the why behind the weight while managing the medication safely.

Your Existing Patients Are Your First Market

Start here: identify current patients who meet FDA criteria (BMI ≥30, or ≥27 with weight-related comorbidities like hypertension or prediabetes). During your next medication review, mention you now offer medical weight management.

This ‘no additional marketing’ approach is the fastest path to your first 20-30 GLP-1 patients. You’ve already established trust. They already know you manage medications thoughtfully. And many are frustrated by weight gain from psychiatric meds—offering them a solution positions you as treating the whole person, not just symptoms in isolation.

One psychiatrist we spoke with started by offering GLP-1s to patients on olanzapine who’d gained 30+ pounds. Within three months, word-of-mouth referrals from those patients filled her Friday afternoon slots entirely with weight-management appointments.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Economics: Cash-Pay vs Insurance (And Why Most Choose Cash)

Let’s talk numbers, because this matters for sustainability.

Most GLP-1 telehealth practices operate on cash-pay models, and for good reason: insurance coverage for obesity treatment remains limited. As of 2024, only 13 state Medicaid programs (including California and Pennsylvania) covered GLP-1 medications for weight loss. Most private insurers cover these drugs for diabetes but exclude obesity treatment—calling it ‘lifestyle’ rather than medical necessity.

This creates a large market of patients willing to pay out-of-pocket. The typical model:

• Initial consultation: $150-300 (45-60 minutes—comprehensive history, labs review, treatment planning, mental health screening)
• Follow-up visits: $75-150 per month (15-20 minute check-ins for dose adjustment, side effect management, progress monitoring)
• Medication costs: $200-400/month for compounded semaglutide through partner pharmacies (vs $1,300+ for brand-name Wegovy without insurance)

A psychiatrist seeing 40 GLP-1 patients monthly (about 2 per day, 4 days a week) generates roughly $4,000-6,000 in monthly visit revenue, plus patients appreciate the transparent pricing. No surprise insurance denials. No prior authorization battles. No waiting weeks for coverage approval while patient motivation wanes.

What About Insurance-Based Models?

Some psychiatrists prefer to bill insurance for obesity counseling (using CPT codes 99201-99215 for E/M visits or G0447 for intensive behavioral therapy). This opens access to patients who can’t afford cash-pay care, and Medicare is piloting coverage for weight-loss drugs in 2026-2027, which could shift the landscape.

The trade-offs: extensive documentation requirements, lower reimbursement rates (often $80-120 per visit vs $150+ cash), and dealing with prior authorizations for medications. Many providers choose a hybrid approach—cash for the comprehensive initial evaluation and early intensive phase, then insurance for routine follow-ups once patients are stable.

Reality check on patient acquisition costs: If you’re thinking about marketing a GLP-1 practice independently, understand the real numbers. Acquiring a qualified psychiatric patient through DIY marketing (Google Ads, SEO, directories) typically costs $200-500+ when you factor in:

• Agency or consultant fees for ad management
• Ad spend testing and optimization (mental health keywords cost $15-40+ per click)
• Staff time to handle and qualify leads
• No-show rates from cold leads
• 6-12 months of SEO investment before meaningful results
• Failed campaigns that don’t convert

Psychology Today charges monthly directory fees but you’re competing with hundreds of providers. Zocdoc charges $35-100+ per booking plus monthly subscription fees. Google Ads for ‘weight loss doctor’ or ‘GLP-1 near me’ are expensive, and most clicks don’t convert to booked patients.

The alternative: Join a platform like Klarity Health that handles patient acquisition through a pay-per-appointment model. You pay a standard listing fee per new patient lead, but critically:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad budget on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

Instead of gambling $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI. For providers starting out or scaling quickly, removing acquisition risk entirely makes the economics work from day one.

State-by-State Rules: What You Need to Know

GLP-1 medications are not controlled substances, which means telehealth prescribing is broadly permitted without the Ryan Haight Act’s in-person exam requirement. However, you must be licensed in the patient’s state, and scope of practice varies—especially for PMHNPs and NPs.

California

• Physicians (MD/DO): Full prescriptive authority with a CA medical license
• PMHNPs: Must operate under physician supervision/protocol unless they achieve independent ‘104 NP’ status (requires 3 years as a ‘103 NP’ first—earliest certifications in Jan 2026)
• Telehealth requirement: Document patient consent for telehealth (verbal or written)
• Market note: California Medicaid covers GLP-1 for obesity as of 2024, potentially increasing insured patient demand in a state with massive population and high cost of living

Texas

• Physicians: Full authority (Texas is in IMLC for expedited multi-state licensing)
• PMHNPs/PAs: Strict supervision required—must have Prescriptive Authority Agreement with a Texas physician (one MD can supervise up to 7 APRNs/PAs)
• Telehealth: Patient relationship can be established via synchronous video without in-person visit, but standard of care must be met
• Market note: High obesity rate (~35%), vast rural underserved areas—strong telehealth demand

Florida

• Physicians: Full license required OR out-of-state providers can register for ‘Florida Telehealth Provider’ status (allows telemedicine without full FL license, but can’t prescribe Schedule II controlled substances—GLP-1s are fine)
• PMHNPs: Require physician collaboration agreement (Florida’s autonomous NP law applies only to primary care NPs, not psychiatric)
• Market note: Large retirement population interested in health improvement; most patients cash-pay since Florida Medicaid doesn’t cover obesity drugs

New York

• Physicians: NY license required (not in IMLC)
• PMHNPs: Independent practice after 3,600 hours (roughly 2 years) of supervised practice—experienced NPs can prescribe without collaborative agreement
• Telehealth: Strong parity laws; no in-person requirement for non-controlled substances
• Market note: Huge NYC market but competitive; upstate and rural areas underserved. Medicaid doesn’t cover GLP-1 for obesity as of 2024

Pennsylvania

• Physicians: PA license required (PA is in IMLC)
• PMHNPs: Must have Collaborative Agreement with a physician—no independent practice pathway exists yet despite legislative attempts
• Telehealth: Video consult sufficient to establish care; no in-person mandate
• Market note: PA Medicaid began covering GLP-1 for obesity in 2024—could drive referrals from primary care

Illinois

• Physicians: IL license required (IL is in IMLC)
• PMHNPs: Full Practice Authority (FPA) available after 4,000 hours of supervised practice + 250 hours additional education—can then prescribe independently
• Telehealth: Comprehensive parity law; telehealth accepted for establishing care
• Market note: Illinois Medicaid covers obesity drugs; strong urban/rural divide creates opportunity

How to Scale Without Burning Out: The Practical Workflow

Here’s where most psychiatrists get stuck: ‘This sounds great, but I’m already maxed out. How do I add 40 weight-loss patients without working nights and weekends?’

The answer is systems, delegation, and boundaries—the same principles that prevent burnout in general psychiatry.

Streamline Your Intake Process

Create a digital intake packet patients complete before their first visit:

• Comprehensive weight history and previous attempts
• Current medications and medical conditions
• Mental health screening (PHQ-9, GAD-7)
• Eating behavior assessment (binge eating, emotional eating patterns)
• Nutrition and exercise baseline
• Motivation and goals

This saves 15-20 minutes of your first appointment and ensures you don’t miss critical information. Build a standardized ‘GLP-1 Initial Evaluation’ template in your EHR with prompts for:

• BMI calculation and baseline weight
• Contraindications check (history of medullary thyroid cancer, pancreatitis, pregnancy)
• Mental health status and psychiatric medication interactions
• Lab orders (A1c, TSH, comprehensive metabolic panel)
• Treatment plan and dosing protocol
• Informed consent for off-label use (if using Ozempic vs Wegovy)
• Side effect education (nausea, injection technique)

The Follow-Up Schedule That Works

Months 1-3: Monthly visits (dose titration phase)
Months 4-6: Every 6-8 weeks (maintenance phase)
Beyond 6 months: Every 2-3 months (stable phase)

But here’s the key: you don’t need to do every follow-up yourself.

Leverage your team:

• Medical assistants or RNs gather interim data before appointments—current weight, blood pressure, symptom questionnaires, medication adherence
• Health coaches or dietitians handle lifestyle counseling, meal planning, exercise support (weekly or biweekly group sessions reduce your one-on-one counseling load)
• Asynchronous check-ins via patient portal for simple questions (‘Is nausea normal at this dose?’)—use templated responses for common issues

One psychiatrist we know runs a weekly 30-minute group Zoom for all her GLP-1 patients led by a health coach. It covers common questions, shares success stories, and provides community support. This reduced her individual counseling time by 60% while actually improving patient outcomes and retention.

Technology: Your Burnout Prevention Tool

Remote patient monitoring: Issue patients a connected scale or ask them to log weekly weights in an app. You can review trends at a glance before appointments instead of spending visit time collecting data.

Template documentation: Create dot phrases or smart phrases for common scenarios:

• ‘.glp1stable’ = ‘Patient tolerating current dose well, no significant side effects, weight loss on track, continuing current regimen’
• ‘.glp1nausea’ = ‘Reports mild nausea, discussed dietary modifications, smaller portions, eating slowly, consider dose hold if worsens’
• ‘.glp1plateau’ = ‘Weight loss plateau noted, reinforced importance of protein intake and resistance training, may increase dose next visit’

Automated appointment reminders and online scheduling reduce no-shows and staff phone time.

AI scribes or documentation assistants can capture visit details, freeing you to focus on the patient rather than typing.

Set Firm Boundaries From Day One

This is non-negotiable:

1. Capacity limits: Start with 1-2 half-days per week dedicated to GLP-1 patients (about 10-12 appointments). As you optimize workflow, you can scale—but don’t jump to 40 patients week one.

2. Communication hours: Set clear expectations about when you respond to messages. Many providers use an auto-reply: ‘Non-urgent messages reviewed within 24-48 hours Monday-Friday. For urgent medical concerns, call [number] or go to ER.’

3. After-hours coverage: Use an answering service for true emergencies. GLP-1 patients rarely have urgent needs, but having a protocol prevents you from feeling ‘on call’ 24/7.

4. Scheduled admin time: Block 30-60 minutes daily for chart review, lab results, refills. Don’t let these tasks bleed into evenings.

Research shows that greater schedule control and virtual practice options significantly reduce physician burnout. Telehealth gives you that flexibility—work from home, set your own hours, take a full lunch break. But you have to enforce those boundaries.

Build in Professional Development

Join communities of practice—obesity medicine forums, telehealth clinician groups, psychiatry subreddits. Learning from others’ workflows and challenges reduces the stress of figuring everything out alone.

Consider pursuing obesity medicine certification (American Board of Obesity Medicine offers a 60-hour online course). Not only does this boost your confidence and clinical knowledge, it’s a marketing differentiator: ‘Board-Certified in Obesity Medicine.’

Monitor your own burnout signs: emotional exhaustion, cynicism about patients, declining work satisfaction. If you notice these, it’s time to reassess your patient load, delegate more tasks, or hire additional support.

The Mental Health Advantage: What You Bring That Others Don’t

Here’s your unfair advantage: You actually understand behavioral change.

Most weight-loss clinics focus purely on medication management. They hand patients a prescription, give generic diet advice, and schedule a follow-up in a month. When patients struggle with motivation, emotional eating, or plateau frustration, they get platitudes—not real psychological support.

You can offer:

Integrated mental health screening: Depression and anxiety often worsen with restrictive dieting. You can identify and treat these issues simultaneously, improving both psychiatric and weight outcomes.

Behavioral counseling that actually works: Motivational interviewing, cognitive reframing of body image issues, addressing emotional eating triggers—these are skills many psychiatrists already use daily.

Managing psychiatric medication side effects: If a patient’s weight loss stalls because their antipsychotic dosage changed, you can adjust both aspects of their care seamlessly.

Addressing the psychological side effects of GLP-1s: Early reports suggested possible mood changes or suicidal ideation with these drugs (though FDA reviews found no clear causal link by 2026). As a psychiatrist, you’re uniquely qualified to monitor and respond to any psychiatric symptoms—a value-add that makes patients feel safer.

One psychiatrist told us: ‘My GLP-1 patients feel like they finally found a doctor who gets it—that weight isn’t just about willpower. When they tell me they binged after a stressful day, I don’t lecture them about calories. We explore the trigger, develop coping strategies, and adjust their medication if needed. That’s why they stay with me.’

Your FAQ: The Questions Every Psychiatrist Asks

Q: Do I need special training or certification to prescribe GLP-1s?
A: No special certification is legally required—psychiatrists (MD/DO) can prescribe these medications with their existing license. However, pursuing obesity medicine CME or certification improves your clinical confidence and marketability. Many psychiatrists complete the ABOM exam or take courses through the Obesity Medicine Association.

Q: What’s my liability risk?
A: GLP-1 medications have well-established safety profiles when used appropriately. Key risk mitigation steps: obtain informed consent (especially for off-label use), screen for contraindications, document baseline labs and follow-up monitoring, educate patients about side effects, and maintain malpractice insurance that covers obesity medicine (inform your carrier about this service line).

Q: Can I prescribe to patients in other states?
A: Only if you hold a medical license in that state. Some states (like Florida) offer streamlined telehealth registration for out-of-state physicians. Others (like Texas, California) require full licensure. The Interstate Medical Licensure Compact (IMLC) expedites multi-state licensing for physicians in member states. Check your state’s participation and requirements.

Q: What if a patient doesn’t lose weight or has serious side effects?
A: Set realistic expectations upfront: GLP-1s produce average 15-20% weight loss over 6-12 months, but individual results vary. Some patients are non-responders. Document your counseling about this. For side effects: most are mild and self-limited (nausea, constipation). Serious side effects (pancreatitis, gallbladder issues) are rare but require stopping medication and appropriate referral. Have clear protocols for when to discontinue treatment.

Q: How do I handle compounded semaglutide vs brand-name medications?
A: Many telehealth practices use compounding pharmacies to offer lower-cost semaglutide ($200-400/month vs $1,300+ for Wegovy). This is legal but requires due diligence: partner only with FDA-registered 503B compounding facilities that use high-quality ingredients. The FDA has warned about substandard compounded products. Document your reasoning and patient consent. Some providers stick exclusively to FDA-approved medications (Wegovy, Saxenda, Zepbound) to avoid any gray areas.

Q: What’s the retention rate for GLP-1 patients?
A: Industry data suggests 60-70% of patients continue treatment for at least 6-12 months. Retention improves dramatically when you provide behavioral support (not just medication) and manage side effects proactively. Patients often discontinue due to cost, plateauing weight loss, or GI side effects—all addressable with good clinical care and patient education.

Your Next Steps: Getting Started

Week 1:

• Identify 5-10 current patients who might benefit from GLP-1 therapy
• Develop your intake packet and consent forms
• Research compounding pharmacy partners or decide on brand-name-only approach

Week 2:

• Create EHR templates for initial evaluation and follow-ups
• Set your pricing structure (initial consult, follow-ups, any package deals)
• Block out designated appointment slots for weight management (start small—one afternoon per week)

Week 3:

• Offer the service to your identified patients
• Set up your first few consultations
• Document everything meticulously to refine your workflow

Month 2:

• Ask early patients for feedback on the experience
• Begin external marketing if desired (website content, social media posts, directory listings)
• Consider joining a telehealth platform for steady patient referrals

Month 3-6:

• Scale gradually based on your capacity and satisfaction
• Hire or delegate to support staff as volume grows
• Track your time investment and revenue to ensure sustainability

Or skip the DIY patient acquisition headache entirely: Join Klarity Health and get matched with pre-qualified patients seeking GLP-1 treatment from psychiatric providers. No upfront marketing costs, no wasted ad spend, no months of SEO work—just qualified patients ready to book. You control your schedule and only pay when you see patients.

[Explore Klarity’s Provider Network →]

The Bottom Line

The GLP-1 weight-loss boom isn’t slowing down—it’s accelerating. Twenty million Americans are already taking these medications, with millions more seeking access. As a psychiatrist, you have clinical skills, prescriptive authority, and a patient population that needs exactly what you can offer.

The question isn’t whether this opportunity exists. It’s whether you’ll build your practice thoughtfully enough to capture it without sacrificing your well-being.

Start small. Systemize ruthlessly. Delegate liberally. Set boundaries firmly.

Do it right, and you’ll build a thriving second revenue stream (or entirely new practice focus) that actually improves your patients’ lives—while protecting the professional sustainability that lets you do this work for years to come.

References

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (May 27, 2025) – https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ (October 20, 2025) – https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. PharmaNewsIntelligence via Schizophrenia.com Forum – ‘Psychiatrists recommend Ozempic’ (November 6, 2023) – https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318

4. MedicalDirectorCo – ‘Texas Weight Loss Clinic Telehealth Compliance Guide’ (2025) – https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/

5. Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny’ (August 22, 2025) – https://time.com/7311517/cost-weight-loss-drugs-skinny/

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is